As of 2026-06-05, the Relative Valuation of XORTX Therapeutics Inc (XRX.CN) is (0.02) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 1.90 CAD, the upside of XORTX Therapeutics Inc based on Relative Valuation is -100.9%.
The range of the Relative Valuation is (0.01) - (0.02) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 0.0x - 0.1x | 0.0x |
| Forward P/E multiples | 0.0x - 0.1x | 0.0x |
| Fair Price | (0.01) - (0.02) | (0.02) |
| Upside | -100.7% - -101.1% | -100.9% |
| Date | P/E |